Seres Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 05/08/2026 | Mar 2026Filed 05/08/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 05/08/2026 | Mar 2025Filed 05/08/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/11/2025 | Mar 2024Filed 05/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0.7 | $0.4 | $0.4 | $0 | $0 | $0 | $0 | $0 | |
| $4.6 | −$20 | $8.2 | −$20 | $33 | $89 | −$33 | −$40 | |
| $0.47 | −$2.08 | $0.94 | −$2.27 | $3.75 | $11.63 | −$4.34 | −$5.49 | |
| 9.7 | 9.6 | 8.8 | 8.7 | 8.7 | — | — | — |
Trend